Literature DB >> 8413628

Prevention of lung reperfusion injury in rabbits by a monoclonal antibody against interleukin-8.

N Sekido1, N Mukaida, A Harada, I Nakanishi, Y Watanabe, K Matsushima.   

Abstract

Re-establishing blood flow to ischaemic tissues causes greater injury than that induced during the ischaemic period. This type of tissue injury, reperfusion injury, is involved in frostbite, multiple organ failure after hypovolaemia and in myocardial infarction. Depletion of neutrophils alleviates reperfusion injury, implying a causal role of neutrophil infiltration. Among members of the recently discovered family of chemotactic cytokines (chemokines), interleukin-8 (IL-8) is a major neutrophil chemotactic and activating factor produced by various types of human cells. We investigated its pathophysiological role in a rabbit model of a lung reperfusion injury. Reperfusion of ischaemic lung caused neutrophil infiltration and destruction of pulmonary structure, as well as local production of IL-8. Furthermore, the administration of a neutralizing monoclonal antibody against IL-8 prevented neutrophil infiltration and tissue injury, proving a causal role of locally produced IL-8 in this model.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8413628     DOI: 10.1038/365654a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  90 in total

Review 1.  Chemokines. Introduction.

Authors:  K Matsushima
Journal:  Springer Semin Immunopathol       Date:  2000

2.  An in vivo approach showing the chemotactic activity of leukotriene B(4) in acute renal ischemic-reperfusion injury.

Authors:  E Noiri; T Yokomizo; A Nakao; T Izumi; T Fujita; S Kimura; T Shimizu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-18       Impact factor: 11.205

3.  Treatment with a monocolonal antibody to IL-8 attenuates the pleocytosis in experimental pneumococcal meningitis in rabbits when given intravenously, but not intracisternally.

Authors:  C Ostergaard; R V Yieng-Kow; C G Larsen; N Mukaida; K Matsushima; T Benfield; N Frimodt-Møller; F Espersen; A Kharazmi; J D Lundgren
Journal:  Clin Exp Immunol       Date:  2000-11       Impact factor: 4.330

4.  Mediators of ischemia-reperfusion injury of rat lung.

Authors:  M J Eppinger; G M Deeb; S F Bolling; P A Ward
Journal:  Am J Pathol       Date:  1997-05       Impact factor: 4.307

Review 5.  Human cellular inflammation in the pathology of acute cerebral ischaemia.

Authors:  C J S Price; E A Warburton; D K Menon
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-11       Impact factor: 10.154

6.  Pulmonary macrophage subpopulations in the induction and resolution of acute lung injury.

Authors:  Laura K Johnston; Cliff R Rims; Sean E Gill; John K McGuire; Anne M Manicone
Journal:  Am J Respir Cell Mol Biol       Date:  2012-06-21       Impact factor: 6.914

7.  Uric acid promotes an acute inflammatory response to sterile cell death in mice.

Authors:  Hajime Kono; Chun-Jen Chen; Fernando Ontiveros; Kenneth L Rock
Journal:  J Clin Invest       Date:  2010-05-24       Impact factor: 14.808

8.  Propofol attenuates pulmonary injury induced by collapse and reventilation of lung in rabbits.

Authors:  Hong-Beom Bae; Mei Li; Seong-Heon Lee; Cheol-Won Jeong; Seok-Jai Kim; Heong-Seok Kim; Sung-Su Chung; Sang-Hyun Kwak
Journal:  Inflammation       Date:  2013-06       Impact factor: 4.092

9.  Prevention of endotoxin-induced acute lethality in Propionibacterium acnes-primed rabbits by an antibody to leukocyte integrin beta 2 with concomitant reduction of cytokine production.

Authors:  N Ikeda; N Mukaida; S Kaneko; N Fujioka; S Su; H Nariuchi; M Unoura; K Harada; Y Nakanuma; K Kobayashi
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

10.  Interleukin 8 and mast cell-generated tumor necrosis factor-alpha in neutrophil recruitment.

Authors:  Y Zhang; B F Ramos; B Jakschik; M P Baganoff; C L Deppeler; D M Meyer; D L Widomski; D J Fretland; M A Bolanowski
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.